Lantheus Holdings Inc

+0.62 (+2.39%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.79B
Current PEN/A
Forward PE 69.97
2yr Forward PE 29.88
See more stats
Estimates Current Quarter
Revenue$94.88 Million
Adjusted EPS$0.05
See more estimates
10-Day MA$25.26
50-Day MA$22.92
200-Day MA$17.41
See more pivots

Lantheus Holdings Inc Stock, NASDAQ:LNTH

331 Treble Cove Road, North Billerica, Massachusetts 01862
United States of America
Phone: +1.978.671.8001
Number of Employees: 595


Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes, and assist clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment operations offers direct distribution in Canada and Puerto Rico; third-party distribution in Europe, Canada, Australia, Asia-Pacific, and Latin America; and EXINI business in Sweden. The company was founded in 1956 and is headquartered in North Billerica, MA.